Holger Weis serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Holger Weis has executed 3 insider transactions totaling $91.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 22, 2022 involved receiving (via award) 40,000 shares valued at $0.
Holger Weis currently holds 160,167 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holger Weis has been a net buyer of ZIOP stock. They have purchased $91.5K and sold $0 worth of shares.
Holger Weis's most recent insider trade was on Jun 22, 2022, when they sold 40,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.83 |
| Discretionary |
| Mar 4, 2021 | ZIOP | $0 | Award | 4,167 | $N/A | Discretionary |